Conducting Public Health Activities in Egypt | RFA GH 17 004

Opportunity Information: Apply for RFA GH 17 004

The grant opportunity titled "Conducting Public Health Activities in Egypt" (Funding Opportunity Number RFA GH 17 004) is a discretionary funding announcement issued by the U.S. Department of Health and Human Services, Centers for Disease Control and Prevention (CDC), using a cooperative agreement mechanism. Its core purpose is to strengthen and expand the capacity of the Egyptian Ministry of Health and Population (MoHP) to better detect, monitor, and respond to emerging infectious diseases in Egypt, with an emphasis that extends to regional public health needs in Northern Africa. In practical terms, the opportunity is aimed at improving the systems and partnerships that allow early identification of outbreaks, faster confirmation of threats, and more effective public health action when new or resurging infectious hazards appear.

A central feature of the opportunity is the role of the MoHP Prevention Sector, which is described as the CDC Global Disease Detection (GDD) center's primary Egyptian health-sector partner. This matters because the Prevention Sector is positioned as the national authority responsible for determining whether public health initiatives are appropriate, ethically managed, and properly approved across all administrative levels in Egypt, including national, governorate, and local settings. The announcement highlights that activities such as infectious disease surveillance and related research require this sector's oversight and authorization, signaling that funded work is expected to align with national governance structures, ethical review expectations, and formal approval pathways. The emphasis on ethical management and appropriateness also suggests that projects under this award would likely involve structured protocols, careful handling of data and specimens where relevant, and compliance with both local and CDC standards for public health practice and research.

Because the funding instrument is a cooperative agreement rather than a standard grant, applicants should read the opportunity as one where CDC anticipates substantial involvement in the work as it is carried out, such as technical collaboration, joint planning, and ongoing coordination. Cooperative agreements are often used when the funder expects to play an active role in shaping implementation to ensure scientific rigor, programmatic alignment, and real-world impact. In this case, that active role would naturally tie into the CDC GDD center presence in Egypt and the need to integrate with the MoHP Prevention Sector's authority and processes, ensuring that project activities are not operating in isolation but are connected to national surveillance, response systems, and decision-making.

The award parameters indicate a single expected award (ExpectedAwards: 1) with an award ceiling of $2,000,000. That combination points to a relatively focused, potentially large-scale effort concentrated in one recipient organization or consortium, designed to produce measurable improvements in public health capacity rather than small, fragmented pilot projects. The funding activity category is Health under CFDA number 93.326, which is commonly associated with CDC infectious disease and global health-related programs. Eligibility is listed broadly as "Others," with additional eligibility details referenced in the full announcement, which typically means the applicant pool may include certain non-traditional entities depending on the specific criteria stated in the original FOA.

Administratively, the opportunity was created on December 8, 2016, with an original closing date of March 24, 2017, and it specifies that electronic submissions were due by 5:00 p.m. Eastern Time on the deadline date. Even though the dates are historical, they still help characterize the opportunity as part of CDC's mid-2010s global health security and emerging infectious disease preparedness efforts, particularly in regions where strengthening surveillance networks and response capacity can have major benefits for both national and cross-border health protection.

Overall, the opportunity is best understood as a capacity-building and applied public health implementation award intended to reinforce Egypt's ability to identify emerging infectious disease threats quickly and respond effectively, while operating through and reinforcing the formal authority of the MoHP Prevention Sector. The structure and language indicate an emphasis on coordination, ethical and governmental approvals, and integration with existing national systems, with CDC playing an engaged partner role through its Global Disease Detection presence in Egypt.

• The Department of Health and Human Services, Centers for Disease Control and Prevention - ERA in the health sector is offering a public funding opportunity titled "Conducting Public Health Activities in Egypt" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.326.
• This funding opportunity was created on Dec 08, 2016.
• Applicants must submit their applications by Mar 24, 2017 Electronically submitted applications must be submitted no later than 500 p.m., ET, on the listed application due date.. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• Each selected applicant is eligible to receive up to $2,000,000.00 in funding.
• The number of recipients for this funding is limited to 1 candidate(s).
• Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).

Apply for RFA GH 17 004

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: